XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Mar. 31, 2019 $ 226 $ 65,094 $ 70,428 $ (2,626) $ 133,122
Balance (in shares) at Mar. 31, 2019 22,607,712        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     8,726   8,726
Cash dividend on common stock     (2,042)   (2,042)
Exercise of stock options $ 1 216     $ 217
Exercise of stock options (in shares) 58,000       58,000
Restricted stock grants (in shares) 82,673        
Stock-based compensation expense   249     $ 249
Other comprehensive income, net       2,847 2,847
Balance at Sep. 30, 2019 $ 227 65,559 77,112 221 143,119
Balance (in shares) at Sep. 30, 2019 22,748,385        
Balance at Jun. 30, 2019 $ 226 65,326 73,602 (491) 138,663
Balance (in shares) at Jun. 30, 2019 22,705,385        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     4,534   4,534
Cash dividend on common stock     (1,024)   (1,024)
Exercise of stock options $ 1 164     165
Exercise of stock options (in shares) 43,000        
Stock-based compensation expense   69     69
Other comprehensive income, net       712 712
Balance at Sep. 30, 2019 $ 227 65,559 77,112 221 143,119
Balance (in shares) at Sep. 30, 2019 22,748,385        
Balance at Mar. 31, 2020 $ 225 64,649 81,870 2,099 148,843
Balance (in shares) at Mar. 31, 2020 22,544,285        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     3,023   3,023
Cash dividend on common stock     (2,227)   (2,227)
Exercise of stock options   9     $ 9
Exercise of stock options (in shares) 5,000       5,000
Stock repurchased $ (3) (1,444)     $ (1,447)
Stock repurchased (in shares) (295,900)        
Restricted stock grants (in shares) 90,763        
Restricted stock cancelled (in shares) (7,913)        
Stock-based compensation expense   206     206
Other comprehensive income, net       639 639
Balance at Sep. 30, 2020 $ 222 63,420 82,666 2,738 149,046
Balance (in shares) at Sep. 30, 2020 22,336,235        
Balance at Jun. 30, 2020 $ 222 63,254 81,240 2,762 147,478
Balance (in shares) at Jun. 30, 2020 22,245,472        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     2,543   2,543
Cash dividend on common stock     (1,117)   (1,117)
Restricted stock grants (in shares) 90,763        
Stock-based compensation expense   166     166
Other comprehensive income, net       (24) (24)
Balance at Sep. 30, 2020 $ 222 $ 63,420 $ 82,666 $ 2,738 $ 149,046
Balance (in shares) at Sep. 30, 2020 22,336,235